3 recruiting, 2 not yet recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 3, Not yet recruiting 2 |
Follow Cutaneous Squamous Cell Carcinoma (CSCC): new trials by email Literature Review of Cutaneous Squamous Cell Carcinoma (CSCC) trials Research Report on Cutaneous Squamous Cell Carcinoma (CSCC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma Cemiplimab, Prednisone, Sirolimus - Kidney Transplant Recipient, Cutaneous Squamous Cell Carcinoma (CSCC) | Phase 2 | Not yet recruiting | Washington University School of Medicine | 22 | 2026-11-30 | 2026-10-15 |
| Flash Radiotherapy for Skin Cancer FLASH radiotherapy, Conventional radiotherapy - Cutaneous Squamous Cell Carcinoma (CSCC), Basal Cell Carcinoma (BCC) | Phase 2 | Recruiting | Jules Bordet Institute | 60 | 2026-08-24 | 2026-11-17 |
| Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma Pucotenlimab, Becotatug Vedotin - Cutaneous Squamous Cell Carcinoma (CSCC) | Phase 2 | Not yet recruiting | Fudan University | 38 | 2026-01-09 | 2026-02-06 |
| MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer Short course radiation, Active Surveillance - Cutaneous Squamous Cell Carcinoma (CSCC) | Phase 2 | Recruiting | University of Vermont Medical Center | 24 | 2025-06-04 | 2026-05-26 |
| Towards Cure Via Only Ultra-short ICB in CSCC Nivolumab, Ipilumimab - Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Cancer | Phase 2 | Recruiting | The Netherlands Cancer Institute | 41 | 2025-05-14 | 2025-05-29 |
Carcinoma, Basal Cell (1) · Head and Neck Neoplasms (1) · Skin Neoplasms (1)
Neoplasms (2) · Neoplasms by Site (2) · Carcinoma (1) · Neoplasms by Histologic Type (1) · Neoplasms, Basal Cell (1) · Neoplasms, Glandular and Epithelial (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Cetuximab (1) · Immunotherapy (1) · Nivolumab (1) · Prednisone (1) · Sirolimus (1) · Watchful Waiting (1) · cemiplimab (1)
Fudan University (1) · Jules Bordet Institute (1) · The Netherlands Cancer Institute (1) · University of Vermont Medical Center (1) · Washington University School of Medicine (1)
United States (2) · Belgium (1) · China (1) · Netherlands (1)
George Ansstas, MD (1) · Lotje Zuur, Prof. Dr. (1) · Naoka Murakami, MD, PhD (1)